These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4125742)

  • 21. Effects of long-term adjuvant chemotherapy with cyclophosphamide (NSC-26271) for radically resected bronchogenic carcinoma.
    Brunner KW; Marthaler T; Müller W
    Cancer Chemother Rep 3; 1973 Mar; 4(2):125-32. PubMed ID: 4199643
    [No Abstract]   [Full Text] [Related]  

  • 22. [Scintigraphy with Hg 197 C1 2 in the diagnosis of bronchogenic carcinoma].
    Bobbio P; Ugolotti G
    Minerva Chir; 1974 Aug; 29(15-16):891-900. PubMed ID: 4422620
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapeutic planning for patients with lung cancer.
    Coles DT
    Surg Clin North Am; 1973 Aug; 53(4):769-74. PubMed ID: 4352128
    [No Abstract]   [Full Text] [Related]  

  • 24. [Radioisotope study of liver function during treatment of lung cancer with cyclophosphane].
    Starinskiĭ VV; Trakhtenberg AKh; Batinov IN
    Med Radiol (Mosk); 1970 Apr; 15(4):32-8. PubMed ID: 5452195
    [No Abstract]   [Full Text] [Related]  

  • 25. Hexamethylmelamine in inoperable bronchogenic carcinoma.
    Takita H
    N Y State J Med; 1972 Feb; 72(4):477-80. PubMed ID: 4334448
    [No Abstract]   [Full Text] [Related]  

  • 26. [Place of chemotherapy in the treatment of primary bronchial cancers].
    Clément F
    Bronches; 1972; 22(3):176-89. PubMed ID: 4349927
    [No Abstract]   [Full Text] [Related]  

  • 27. Bronchial artery infusion of mitomycin-C in advanced bronchogenic carcinoma.
    Hellekant C; Svanberg L
    Acta Radiol Oncol Radiat Phys Biol; 1978; 17(6):449-62. PubMed ID: 83780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiotherapy for bronchogenic carcinoma: actual difficulties and plans for the future.
    Dana M
    Cancer Chemother Rep 3; 1973 Mar; 4(2):153-5. PubMed ID: 4734076
    [No Abstract]   [Full Text] [Related]  

  • 29. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
    Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
    Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of chemotherapy in the treatment of lung cancer.
    Selawry OS
    Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
    [No Abstract]   [Full Text] [Related]  

  • 31. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Bitran JD; Desser RK; DeMeester T; Golomb HM
    JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy of inoperable bronchogenic carcinoma.
    Behera D; Malik SK
    Indian J Chest Dis Allied Sci; 1985; 27(3):175-89. PubMed ID: 3017850
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of the behavior of radiomercury and of its ratio of fixation to resected pulmonary tissue: preliminary note, with special reference to technic].
    Massei V; Miti L; Radelmacher G; Sanguinetti CM; Trotti-Maina G; Vallese P
    Minerva Med; 1974 Nov; 65(84):4362-71. PubMed ID: 4437783
    [No Abstract]   [Full Text] [Related]  

  • 34. Bleomycin, cisplatin, vincristine, and methotrexate in advanced non-small cell bronchogenic carcinoma.
    Rosenthal CJ; Ritter S; Platica O
    Cancer Treat Rep; 1982 Jan; 66(1):205-6. PubMed ID: 6171350
    [No Abstract]   [Full Text] [Related]  

  • 35. [Primary bronchogenic carcinoma in a vine-grower. Role of arsenates].
    Poirier R; Favre R; Kleisbauer JP; Ingenito G; Paoli J; Laval P; Serafino X
    Nouv Presse Med; 1973 Jan; 2(2):91-2. PubMed ID: 4685772
    [No Abstract]   [Full Text] [Related]  

  • 36. [The chelation of various radioactive cations by some polypeptides, used as a labelling method. Application to bleomycin].
    Renault H; Rapin J; Wicart L
    C R Acad Hebd Seances Acad Sci D; 1971 Nov; 273(21):2013-5. PubMed ID: 4109539
    [No Abstract]   [Full Text] [Related]  

  • 37. New agents and combinations in the treatment of bronchogenic carcinoma.
    Bodey GP; Gottlieb JA; Livingston R; Frei E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of radiologic and cytostatic combination therapy in malignant diseases].
    Hammer B
    Wien Med Wochenschr; 1967 Jun; 117(25):637-41. PubMed ID: 5585442
    [No Abstract]   [Full Text] [Related]  

  • 39. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
    Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
    Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical evaluation of an innoxious antineoplastic agent: preliminary study of 106 patients treated with or without RSV after pulmonary resection for bronchogenic carcinoma.
    Hansen JL
    Cancer Chemother Rep 3; 1973 Mar; 4(2):261-4. PubMed ID: 4729327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.